awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26777736-E7AA4BEF-DB46-4F30-8DDE-C1AC6DDF686A
Q26777736-E7AA4BEF-DB46-4F30-8DDE-C1AC6DDF686A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26777736-E7AA4BEF-DB46-4F30-8DDE-C1AC6DDF686A
Targeted Therapies in Triple-Negative Breast Cancer
P2860
Q26777736-E7AA4BEF-DB46-4F30-8DDE-C1AC6DDF686A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26777736-E7AA4BEF-DB46-4F30-8DDE-C1AC6DDF686A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c96b2664a767fd0e743ccaed6cf8b88a52e4abb6
P2860
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer